NVS vs. T

Last updated Jul 21, 2026

NVS (Novartis AG) and T (AT&T Inc.) are both stocks. NVS operates in Drug Manufacturers - General (Healthcare), while T operates in Telecom Services (Communication Services). Over the past 10 years, NVS returned 9.95%/yr vs 2.10%/yr for T. At a 0.27 correlation, their price movements are largely independent.

Performance

NVS vs. T - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NVS) and AT&T Inc. (T). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NVS achieves a 11.78% return, which is significantly higher than T's -7.04% return. Over the past 10 years, NVS has outperformed T with an annualized return of 9.95%, while T has yielded a comparatively lower 2.10% annualized return.

NVS

• 1D: -2.73%
• 1M: 1.69%
• 6M: 6.77%
• YTD: 11.78%
• 1Y: 34.89%
• 3Y*: 16.47%
• 5Y*: 14.79%
• 10Y*: 9.95%
• ALL TIME*: 8.95%

T

• 1D: 0.64%
• 1M: 2.62%
• 6M: -2.84%
• YTD: -7.04%
• 1Y: -13.37%
• 3Y*: 20.93%
• 5Y*: 7.13%
• 10Y*: 2.10%
• ALL TIME*: 9.35%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NVS vs. T - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NVS Novartis AG	11.78%	46.95%	0.02%	16.14%	8.06%	-3.65%	3.34%	13.92%	5.95%	19.42%
T AT&T Inc.	-7.04%	13.97%	44.08%	-2.74%	5.76%	-8.09%	-21.37%	45.55%	-22.25%	-4.01%

Correlation

The correlation between NVS and T is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (5Y) Calculated over the trailing 5-year period	0.25
Correlation (10Y) Calculated over the trailing 10-year period	0.25
Correlation (All Time) Calculated using the full available price history since Nov 7, 1996	0.27

The correlation between NVS and T shifts across timeframes, from 0.14 (1 year) to 0.27 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap NVS : $285.37B T : $152.52B
EPS NVS : $7.02 T : $3.05
PE Ratio NVS : 21.31 T : 7.19
PEG Ratio NVS : 1.44 T : 0.30
PS Ratio NVS : 5.15 T : 1.25
Total Revenue (TTM) NVS : $56.05B T : $125.65B
Gross Profit (TTM) NVS : $42.19B T : $105.41B
EBITDA (TTM) NVS : $22.40B T : $54.70B

Return for Risk

NVS vs. T — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVS

NVS Risk / Return Rank: 85
NVS Sharpe Ratio Rank: 87
NVS Sortino Ratio Rank: 84
NVS Omega Ratio Rank: 82
NVS Calmar Ratio Rank: 85
NVS Martin Ratio Rank: 84

T

T Risk / Return Rank: 22
T Sharpe Ratio Rank: 19
T Sortino Ratio Rank: 19
T Omega Ratio Rank: 20
T Calmar Ratio Rank: 29
T Martin Ratio Rank: 23

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVS vs. T - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and AT&T Inc. (T). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NVS	T	Difference
Sharpe ratio: Return per unit of total volatility	1.63	-0.57	+2.20
Sortino ratio: Return per unit of downside risk	2.31	-0.67	+2.97
Omega ratio: Gain probability vs. loss probability	1.28	0.92	+0.36
Calmar ratio: Return relative to maximum drawdown	2.77	-0.46	+3.24
Martin ratio: Return relative to average drawdown	6.58	-1.03	+7.62

NVS vs. T - Sharpe Ratio Comparison

The current NVS Sharpe Ratio is 1.63, which is higher than the T Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of NVS and T, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NVS vs. T - Drawdown Comparison

The maximum NVS drawdown since its inception was -42.10%, smaller than the maximum T drawdown of -64.15%. Use the drawdown chart below to compare losses from any high point for NVS and T.

Drawdown Indicators

	NVS	T	Difference
Max Drawdown Largest peak-to-trough decline	-42.10%	-64.15%	+22.05%
Max Drawdown (1Y) Largest decline over 1 year	-12.65%	-28.89%	+16.24%
Max Drawdown (3Y) Largest decline over 3 years	-19.95%	-28.89%	+8.94%
Max Drawdown (5Y) Largest decline over 5 years	-20.42%	-32.01%	+11.59%
Max Drawdown (10Y) Largest decline over 10 years	-26.03%	-42.35%	+16.32%
Current Drawdown Current decline from peak	-8.60%	-21.57%	+12.97%
Average Drawdown Average peak-to-trough decline	-10.91%	-15.74%	+4.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.31%	12.94%	-7.63%

Volatility

NVS vs. T - Volatility Comparison

The current volatility for Novartis AG (NVS) is 8.03%, while AT&T Inc. (T) has a volatility of 9.59%. This indicates that NVS experiences smaller price fluctuations and is considered to be less risky than T based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVS	T	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.03%	9.59%	-1.56%
Volatility (6M) Calculated over the trailing 6-month period	15.98%	19.91%	-3.93%
Volatility (1Y) Calculated over the trailing 1-year period	21.51%	23.72%	-2.21%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.18%	24.38%	-5.20%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.69%	23.92%	-4.23%

Dividends

NVS vs. T - Dividend Comparison

NVS's dividend yield for the trailing twelve months is around 3.19%, less than T's 6.58% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVS Novartis AG	3.19%	2.90%	3.84%	3.44%	3.70%	3.86%	3.22%	3.03%	3.47%	3.24%	3.73%	3.10%
T AT&T Inc.	6.58%	4.47%	4.87%	6.62%	6.66%	8.46%	7.23%	5.22%	7.01%	5.04%	4.51%	5.46%

Financials

Frequently Asked Questions

Can I hold both NVS and T in my portfolio?

NVS and T have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NVS or T?

T has higher volatility (9.59%) compared to NVS (8.03%). In terms of maximum drawdown, NVS dropped -42.10% vs T's -64.15%.

Which has better risk-adjusted returns?

NVS currently has the higher Sharpe Ratio (1.63 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.